Integrin α5 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells

Cisplatin, as one of the front-line chemotherapeutic drugs, is employed for the treatment of esophageal squamous cell carcinoma (ESCC). However, the occurrence of cisplatin resistance and metastasis remain as challenges in clinical therapy. To investigate the mechanism involved in cisplatin resistan...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Hou, Sicong, Jin, Weiguo, Xiao, Weiming, Deng, Bin, Wu, Dacheng, Zhi, Jiehua, Wu, Keyan, Cao, Xiaowei, Chen, Shuai, Ding, Yanbing, Shi, Hongcan
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943361/
https://ncbi.nlm.nih.gov/pubmed/31911861
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars